The Economic Burden of Early-Stage Chronic Kidn...

By HEOR Staff Writer

January 18, 2024

The Silent Burden of Early-Stage CKD Chronic kidney disease (CKD) is a silent epidemic, affecting 9.1% of the global population. Both end-stage renal disease (ESKD) and cardiovascul...
A Potential Solution for Acute Heart Failure Hospitalisation
Direct Oral Anticoagulants Efficacy Versus Vitamin K Antagonists
Improvements in Frailty Care as Cost Effective
ISPOR’s Top 10 HEOR Trends for 2024-2025
Pharmaceutical Pricing and Reimbursement in Latin America
Antimicrobial Resistance Cost in Two Ghanaian Hospitals
A Closer Look at Access to Essential Medicines in South Sudan
A Closer Look at Global Health Research and Development
The Power of Public Health: A Look at South Africa’s HIV Treatment Prog...
Addressing the Disparity: Treating Childhood Cancer in Low and Middle-Income ...
The National Health Insurance Bill: Passed at NCOP
Unravelling the Impact of Bolsa Família Program on Birth Weight Indicators in...